Curis Stock (NASDAQ: CRIS) stock price, news, charts, stock research, profile.
Open | $6.49 |
Close | - |
Volume / Avg. | 29.82K / 28.03K |
Day Range | 6.08 - 6.64 |
52 Wk Range | 3.80 - 17.49 |
Market Cap | $41.02M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 25 |
Short Interest | 0.65% |
Days to Cover | 1.14 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Curis (NASDAQ:CRIS) through any online brokerage.
Other companies in Curis’s space includes: Fortress Biotech (NASDAQ:FBIO), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX), CARISMA Therapeutics (NASDAQ:CARM) and Immuneering (NASDAQ:IMRX).
There is no analysis for Curis.
Curis has a consensus price target of $16.25.
The stock price for Curis (NASDAQ: CRIS) is $6.1 last updated Today at July 22, 2024 at 2:44 PM EDT.
There are no upcoming dividends for Curis.
Curis’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Curis.
Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.